Skip to content

Clinical study on the feasibility of not placing abdominal drainage tube and jejunal nutrition tube/gastrointestinal decompression tube after laparoscopic radical gastrectomy

Clinical study on the feasibility of not placing abdominal drainage tube and jejunal nutrition tube/gastrointestinal decompression tube after laparoscopic radical gastrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069206
Enrollment
Unknown
Registered
2023-03-09
Start date
2023-03-09
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric or gastroesophageal junction adenocarcinoma

Interventions

Tube group:With abdominal drainage tube, nasogastric decompression tube or nasojejunal nutrition tube after operation
Tubeless group:Without abdominal drainage tube, nasogastric decompression tube or nasojejunal nutrition tube after operation

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of gastric or gastroesophageal junction adenocarcinoma; 2. Preoperative evaluation showed clear indications without surgical contraindications; 3. Patients’ age from 18 to 80 years old; 4. ECOG score of 0-1; 5. Clinical tumor stage of cT1-4N0-3M0; 6. The surgical methods were laparoscopic radical gastrectomy (including direct laparoscopic radical gastrectomy for early gastric cancer, laparoscopic radical gastrectomy for advanced gastric cancer after neoadjuvant therapy, and laparoscopic radical gastrectomy for advanced gastric cancer after successful conversion therapy); 7. Obtain the consent of the patient after informing the purpose of the study, and sign the informed consent of the operation and clinical study.

Exclusion criteria

Exclusion criteria: 1. With other serious complications. 2. Patients with tumor hemorrhage, and pyloric obstruction, recurrent or remnant gastric cancer. 3. Patients who underwent emergency or other gastrointestinal surgeries. 4. Patients with distant metastasis or simultaneous tumors in other parts of the body preoperatively and intraoperatively. 5. Patients with extensive intraperitoneal adhesions and significant tissue edema intraoperatively. 6. Patients with combined thoracic and abdominal esophagogastrectomy or combined organ resection. 7. Patients with preoperative pathological examination inconsistent with postoperative result. 8. Declined to participate. 9. Patients with poor compliance and withdrew from the study halfway.

Design outcomes

Primary

MeasureTime frame
Postoperative hospital stay;

Secondary

MeasureTime frame
Operation time;Complications;Number of lymph nodes retrieved;Postoperative numeric rating scale score;Postoperative prognostic nutritional index value;QoR-15 score;The first time to get out of bed after operation;Postoperative ventilation time;Postoperative fluid diet time;EORTC QLQ-C30 score;Hospitalization expenses;

Countries

China

Contacts

Public ContactJiao Zuoyi

Lanzhou University Second Hospital

longbo_107@163.com+86 130 0878 1208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026